Literature DB >> 8094039

T cell receptor haplotypes in families of patients with insulin-dependent diabetes mellitus.

H Kelly1, M J Garlepp.   

Abstract

The frequencies of Bgl 11 and BamH1 restriction fragment length polymorphisms (RFLP) of C beta, V beta 8, V beta 11 and V beta 7.2 have been defined in a healthy Australian population. Linkage disequilibrium between alleles of the T cell receptor (TCR) V beta 8 and V beta 11 gene segments has been confirmed. We have also confirmed the lack of linkage disequilibrium between either of these loci and alleles at C beta or V beta 7.2. Using RFLPs at V beta 11 and V beta 8 loci TCR beta haplotypes have been identified in five families in which the probands have insulin-dependent diabetes mellitus (IDDM). An extremely rare haplotype, marked by the higher molecular weight BamH1 allele (H, H) at each of V beta 11 and V beta 8, was found in the DR4+ DR3- probands of two families (P = 0.004). In three families in which the probands had DR3, the more common TCR haplotype LH (V beta 11, V beta 8) was found. Taken together, these data confirm that linkage disequilibrium does exist in the TCR beta locus, at least in some regions, and suggest that detailed analysis of the relationship between TCR V beta haplotypes and HLA is warranted since these RFLPs may be markers for important allelic V gene sequence variations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094039      PMCID: PMC1554681          DOI: 10.1111/j.1365-2249.1993.tb05887.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics.

Authors:  J L Jorgensen; U Esser; B Fazekas de St Groth; P A Reay; M M Davis
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

2.  Association of HLA-DR phenotypes and T-lymphocyte-receptor beta-chain-region RFLP with IDDM in Japanese.

Authors:  M Ito; M Tanimoto; H Kamura; M Yoneda; Y Morishima; K Takatsuki; T Itatsu; H Saito
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

3.  Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus.

Authors:  D P Singal; M A Blajchman
Journal:  Diabetes       Date:  1973-06       Impact factor: 9.461

4.  HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus.

Authors:  M L Hoover; G Angelini; E Ball; P Stastny; J Marks; J Rosenstock; P Raskin; G B Ferrara; R Tosi; J D Capra
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

5.  The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis.

Authors:  S S Beall; P Concannon; P Charmley; H F McFarland; R A Gatti; L E Hood; D E McFarlin; W E Biddison
Journal:  J Neuroimmunol       Date:  1989-01       Impact factor: 3.478

6.  HLA and insulin gene associations with IDDM.

Authors:  G Thomson; W P Robinson; M K Kuhner; S Joe; W Klitz
Journal:  Genet Epidemiol       Date:  1989       Impact factor: 2.135

7.  Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.

Authors:  H Kelly; V J McCann; P H Kay; R L Dawkins
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  T cell receptor beta chain polymorphisms are associated with insulin-dependent diabetes.

Authors:  B A Millward; K I Welsh; R D Leslie; D A Pyke; A G Demaine
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

9.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Human T cell receptor V beta gene polymorphism.

Authors:  P Concannon; R A Gatti; L E Hood
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

View more
  1 in total

1.  Genetics of inflammatory bowel disease.

Authors:  J Satsangi; D P Jewell; W M Rosenberg; J I Bell
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.